Prospective cohort patients with Multiple sclerosis and controls
The sys4MS cohort comprises 350 patients with Multiple Sclerosis (MS) and 9 controls, with 2 years of follow-up. Baseline data includes demographics, clinical scales, disease duration and subtype and use of disease-modifying drugs, brain MRI (volumetry and lesion load), retinal thickness by OCT, genomics (GWAS), cytomics, and phosphoproteomics. Data at the end of follow-up includes clinical scales, brain MRI and OCT.
- 17/05/2023
- 400 samples
- DAC: EGAC00001003224
- Technology: Illumina HumanOmniExpress-24 v1.2 array
Access to the Sys4MS cohort will be granted to scientific projects with enough merit and upon reasonable request
Access to the Sys4MS cohort will be granted to scientific projects with enough merit and upon reasonable request.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |